Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31483721 | 0.87 | HTT (0.64) | HPGDKMT2AL3MBTL1ALDH1A1HTT | |
| SCHEMBL26417076 | 0.87 | HTT (0.64) | HPGDKMT2AL3MBTL1ALDH1A1HTT | |
| SCHEMBL4155532 | 0.85 | KMT2A (0.50) | HPGDMAPK1NPC1RAB9AKMT2A | |
| SCHEMBL13477779 | 0.85 | ALDH1A1 (0.58) | HPGDSMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL31686014 | 0.85 | HPGD (0.64) | HPGDSMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL461599 | 0.85 | HPGD (0.64) | HPGDSMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL10604035 | 0.84 | HPGD (0.66) | HPGDSMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL23689774 | 0.82 | HPGD (0.64) | HPGDSMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL11146831 | 0.82 | HPGD (0.64) | HPGDSMN1; SMN2MAPK1NPC1RAB9A | |
| SCHEMBL17214430 | 0.82 | HPGD (0.64) | HPGDSMN1; SMN2MAPK1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303291-A1 | ROR GAMMA (ROR ) MODULATORS | Lead Pharma Holding B.V. (NL) | 2018-04-11 | — | — | EP | claimed |
| WO-2016193452-A1 | ROR GAMMA (RORγ) MODULATORS | LEAD PHARMA CEL MODELS IP B.V. (NL) | 2016-12-08 | — | — | WO | claimed |
| CN-103649087-A | Substituted imidazopyridines and intermediates thereof | BAYER IP GMBH | 2014-03-19 | — | — | CN | claimed |
| EP-0287421-B1 | PROCESS FOR THE CYCLIC PRODUCTION OF HYDROGEN PEROXIDE | ELF ATOCHEM S.A. (FR) | 1991-06-05 | — | — | EP | claimed |
| US-4803063-A | REDOX REACTION OF QUINONES IN AROMATIC AMIDE SOLVENT | ATOCHEM (FR) | 1989-02-07 | — | — | US | claimed |
| EP-0287421-A1 | Process for the cyclic production of hydrogen peroxide | ELF ATOCHEM S.A. (FR) | 1988-10-19 | — | — | EP | claimed |
| US-12628827-B2 | Isoxazoline compounds and their use as pest control agents | PI INDUSTRIES LIMITED (IN) | 2026-05-19 | — | — | US | disclosed |
| CN-117355373-B | Ethylene oligomerization process | 切弗朗菲利浦化学公司 | 2025-05-16 | — | — | CN | disclosed |
| EP-4545620-A2 | ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-113227089-B | Substituted 6-azabenzimidazole compounds as HPK1 inhibitors | 吉利德科学公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118044519-A | Molecules having pesticidal utility, and intermediates, compositions and methods related thereto | 科迪华农业科技有限责任公司 | 2024-05-17 | — | — | CN | disclosed |
| US-20240057604-A1 | ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | PI INDUSTRIES LTD. (IN) | 2024-02-22 | — | — | US | disclosed |
| CN-110072842-B | Molecules having pesticidal utility, and intermediates, compositions and methods related thereto | 科迪华农业科技有限责任公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20070060510-A1 | Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2007-03-15 | — | — | US | disclosed |
| US-7176208-B2 | Prevent reproduction of hepatitis virus | ENANTA PHARMACEUTICALS, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| EP-0287421-B1 | PROCESS FOR THE CYCLIC PRODUCTION OF HYDROGEN PEROXIDE | ELF ATOCHEM S.A. (FR) | 1991-06-05 | — | — | EP | disclosed |
| US-4803063-A | REDOX REACTION OF QUINONES IN AROMATIC AMIDE SOLVENT | ATOCHEM (FR) | 1989-02-07 | — | — | US | disclosed |
| EP-0287421-A1 | Process for the cyclic production of hydrogen peroxide | ELF ATOCHEM S.A. (FR) | 1988-10-19 | — | — | EP | disclosed |
| US-4083997-A | ANTIDEPRESSANTS | SANDOZ, INC. (US) | 1978-04-11 | — | — | US | disclosed |
| US-3994961-A | ANTIDEPRESSANTS | SANDOZ, INC. (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12628827-B2 | Isoxazoline compounds and their use as pest control agents | HCN1, CBR3, SCN1B | HPGD 4270/4885SMN1; SMN2 1742/4885MAPK1 3573/4885 |
| US-20240057604-A1 | ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS | PRDX1, RDX, PRDX2 | HPGD 2659/4885SMN1; SMN2 2742/4885MAPK1 2668/4885 |
| US-20070060510-A1 | Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors | PRSS1, SPINT2, HPN | HPGD 449/4885SMN1; SMN2 3819/4885MAPK1 1848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.